蛋白多肽类口服给药系统
黄敏,吴伟
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation): 上海市科技发展基金资助项目 (批准号 :0 2 43 1914 )
作者(Author): 黄敏,吴伟
Email:
参考文献(References)：
- [1]NakamotoT ,KasaokaY ,MitaniS ,etal.Inhalationofinterleukin2combinedwithsubcutaneousadministrationofinterferonforthetreatmentofpulmonarymetastasesfromrenalcellcarcinoma[J].IntJUrol,1997,4(4):343.
- [2]文爱东.吸收促进剂在口服制剂中增强药物生物利用度的作用[J].国外医学·药学分册,2000,27(6):354.
- [3]SalamaNN ,FasanoA ,LuR ,etal.Effectifthebiologicallyactivefrag mentofzonulaoccludentstoxin,deltaG ,ontheintestinalparacellulartransportandoralabsorptionofmannitol[J].IntJPharm,2003,251(12):113.
- [4]LeeHJ,AmidonGL .Theeffectofenzymeinhibitorandabsorptionsitefollowing[D ala2,D leu5]enkephalinoraladministrationinrats[J].BiopharmDrugDispos,2000,23(4):131.
- [5]PaulettiGM ,GangwarS ,SiahaanTJ ,etal.Improvementoforalpep tidebioavailability:Peptidomimeticsandprodrugstrategies[J].AdvDrugDelRev,1997,27(23):235.
- [6]HershfieldMS .Genotypeisanimportantdeterminantofphenotypeinadenosinedeaminasedeficiency[J].CurrentOpinioninImmunyogy,2003,15(5):571.
- [7]GershonovE ,GoldwaserI,FridkinM ,etal.Anovelapproachforawater solublelong actinginsulinprodrug:design,preparation,andanalysisof[(2 sulfo)9 fluorenylmethoxycarbonyl](3) insulin[J].JMedChem,2000,43(13):2530.
- [8]RussellJonesGJ,AlpersDH .VitaminB12transporters[J].PharmBiotechnol,1999,12(1):493.
- [9]MackayM ,PillipsJ,HastewellJ.Peptidedrugdelivery:Colonicandrectalabsorption[J].AdvDrugDelRev,1997,28(2):253.
- [10]魏淑波.口服生物黏附性给药系统[J].镇江医学院学报,2001,11(1):108.
- [11]刘梅.壳聚糖及其衍生物在肽类口服给药系统的应用[J].国外医学药·学分册,2000,27(6):351.
- [12]PanY ,LiYJ ,ZhaoHY ,etal.Bioadhesivepolysaccharideinproteindeliverysystem:chitosannanoparticlesimprovetheintestinalabsorptionofinsulininvivo[J].IntJPharm,2002,249(12):139.
- [13]FlorenceAT ,SakthivelT ,TothI.Oraluptakeandtranslocationofapolylysinedendrimerwithalipidsurface[J].JControlledRelease,2000,65(12):253.
- [14]KoflerN ,RuedlC ,WickG ,etal.Gastrointestinaluptakeofbiodegradablemicroparticles:effectofparticlesize[J].IntArchAl lergyImmunol,1997,113(4):11421.
- [15]FuentesMG ,TorresD ,AlonsoMJ.Designoflipidnanoparticlesfortheoraldeliveryofhydrophilicmacromolecules[J].ColloidsandSur facesB :Biointerfaces,2003,27(23):159.
- [16]TakeuchiH ,YamamotoH ,KawashimaY .Mucoadhesivenanoparticu latesystemsforpeptidedrugdelivery[J].AdvDrugDelRev,2001,47(1):39.
- [17]KawashimaY ,YamamotoH ,TakeuchiH ,etal.MucoadhesiveDL -lactide/glycolidecopolymernanospherescoatedwithchitosantoimproveoraldeliveryofelcatonin[J].PharmDevTechnol,2000,5(1):77.
- [18]JungT ,KammW ,BreitenbaxhA ,etal.Biodegradablenanoparticlesfororaldeliveryofpeptides:Istherearoleforpolymerstoaffectmu cosaluptake[J]?EurJPharmBiopharm,2000,50(1):147.
- [19]silvaCunhaA ,Che’ronM ,GrossiordGL ,etal.W/O/Wmultipleemulsionsofinsulincontainingaproteaseinhibitorandanabsorptionenhance:biologicalactivityafteroraladministrationtonormalanddia beticrats[J].IntJpharm,1998,169(1):33.
- [20]LyonsKC ,CharmanWN ,MillerR ,etal.FactorslimitingtheoralbioavailabilityofN acetylglucosaminylN acetylmuramyldipeptide(GMDP)andenhancementofaborptioninratsbydeliveryinawaterin oilmicroemusion[J].IntJPharm,2000,199(1):17.
- [21]张志清,智丽敏.环孢素A新制剂研究进展[J].中国药学杂志,2002,37(9):643.
- [22]KiselMA ,KulikLN ,TsybovskyIS ,etal.Liposomeswithphos phatidylethanolasacarrierfororaldeliveryofinsulin:studiedintherat[J].IntJPharm,2001(12):105.
- [23]TakeuchiH ,YamamotoH ,KawashimaY .Mucoadhesivenanoparticu latesystemsforpeptidedrugdelivery[J].AdvDrugDelivRe,2001,47(1):39.
- [24]PageDT ,CudmoreS .Innovationsinoralgenedelivery:challengesandpotentials[J].DrugDiscovtoday,2001,6(2):92.